VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹48 Cr | ₹41 Cr | ₹21 Cr | ₹6.85 Cr |
What is the latest Consolidated Net Profit of VIMTA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
| Mar2020 | ₹6.85 Cr |
How is Consolidated Net Profit of VIMTA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹41 Cr | -14.87 | |
| Mar2023 | ₹48 Cr | 16.55 | |
| Mar2022 | ₹41 Cr | 93.09 | |
| Mar2021 | ₹21 Cr | 212.71 | |
| Mar2020 | ₹6.85 Cr | - | |
Compare Consolidated Net Profit of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,966.9 Cr | -13.4% | -27.3% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -13.4% |
-27.3% |
-1.3% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses